Hilma Biocare – Semaglutide (Ozempic) (2 mg/vial)
Semaglutide (Ozempic) is a GLP-1 Receptor Agonist used to manage type 2 diabetes and support weight loss through subcutaneous injection.
- The description claims that Semaglutide (Ozempic) aids in reducing 10-15% of total body weight.
- The description claims that Semaglutide (Ozempic) helps control diabetes.
AI Readiness
Good foundation, but some important product data is still missing.
72%